PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Rating of Buy by Analysts

Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) have earned a consensus rating of “Buy” from the seven research firms that are presently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have issued a report on […]

Related Keywords

United States ,Thomasm Krummel ,Piper Sandler ,Alaleh Nouri ,Nasdaq ,Biorobotics Company Profile ,Biorobotics Corporation ,Blue Trust Inc ,Biorobotics Co ,Fairman Group ,Securities Exchange Commission ,Jump Financial ,Get Free Report ,Marketbeat Ratings ,Truist Financial ,Exchange Commission ,Director Thomas ,Jacobson Investment Advisors ,Robotics Company ,Get Free ,Robotics Corporation ,Aquabeam Robotic System ,Robotics Daily ,